We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-1 of 1

U.S. Supreme Court: disclosing “statistically significant” incidents regarding a product’s potential adverse health effects is not enough

  • Kelley Drye & Warren LLP
  • -
  • USA
  • -
  • March 29 2011

The Supreme Court recently issued a unanimous decision in a securities fraud case, Matrixx Initiatives, Inc. v. Siracusano